Search research articles
Contact Us
Filters
Showing results (121-130 of 343) with videos related to
Page
of 35
Sort By:
Leukemia & Lymphoma
|
May 26, 2020
Clinicopathologic characteristics and survival of patients with primary effusion lymphoma
Cristian Aguilar, Caddie Laberiano, Brady Beltran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2019
Reply to F.D. Leonard
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Haematologica
|
October 31, 2024
Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis
Bryan Valcarcel, Sara J Schonfeld, Meredith S Shiels, et al.
Leukemia & Lymphoma
|
January 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia
Shayna Sarosiek, Jorge J Castillo, Zachary R Hunter, et al.
American Journal of Hematology
|
May 15, 2026
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management
Jorge J Castillo, Brady E Beltrán, Jorge A Florindez, et al.
JACC. Cardiooncology
|
August 16, 2021
Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma
Colin A Martz, Jennifer F Jarbeau, Jorge J Castillo, et al.
American Journal of Hematology
|
March 20, 2016
Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia
Joshua N Gustine, Kirsten Meid, Toni E Dubeau, et al.
British Journal of Haematology
|
February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndrome
Shayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.
British Journal of Haematology
|
November 3, 2015
Rituximab intolerance in patients with Waldenström macroglobulinaemia
Jorge J Castillo, Sandra Kanan, Kirsten Meid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 20, 2019
High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy
Brady E Beltran, Sally Paredes, Denisse Castro, et al.
Page
of 35
Search research articles
Search
Showing results (121-130 of 343) with videos related to
Sort By:
Page
of 35
Leukemia & Lymphoma
|
May 26, 2020
Clinicopathologic characteristics and survival of patients with primary effusion lymphoma
Cristian Aguilar, Caddie Laberiano, Brady Beltran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2019
Reply to F.D. Leonard
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Jorge J Castillo, et al.
Haematologica
|
October 31, 2024
Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis
Bryan Valcarcel, Sara J Schonfeld, Meredith S Shiels, et al.
Leukemia & Lymphoma
|
January 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia
Shayna Sarosiek, Jorge J Castillo, Zachary R Hunter, et al.
American Journal of Hematology
|
May 15, 2026
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management
Jorge J Castillo, Brady E Beltrán, Jorge A Florindez, et al.
JACC. Cardiooncology
|
August 16, 2021
Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma
Colin A Martz, Jennifer F Jarbeau, Jorge J Castillo, et al.
American Journal of Hematology
|
March 20, 2016
Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia
Joshua N Gustine, Kirsten Meid, Toni E Dubeau, et al.
British Journal of Haematology
|
February 19, 2025
Zanubrutinib for the treatment of Bing-Neel syndrome
Shayna Sarosiek, Andres Ramirez-Gamero, Catherine A Flynn, et al.
British Journal of Haematology
|
November 3, 2015
Rituximab intolerance in patients with Waldenström macroglobulinaemia
Jorge J Castillo, Sandra Kanan, Kirsten Meid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 20, 2019
High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy
Brady E Beltran, Sally Paredes, Denisse Castro, et al.
Page
of 35